CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+21.32%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.39B
AUM Growth
+$1.39B
(+12%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
65
New
8
Increased
5
Reduced
40
Closed
4
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$43.4M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$27.3M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$24.8M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$17.2M |
| 5 |
Zai Lab
ZLAB
|
$9.25M |
Top Sells
| 1 |
Vanda Pharmaceuticals
VNDA
|
$18.2M |
| 2 |
Quanterix
QTRX
|
$17M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$13.3M |
| 4 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$11.8M |
| 5 |
MTVA
MetaVia Inc. Common Stock
MTVA
|
$10.6M |
Sector Composition
| 1 | Healthcare | 95.68% |
